Home > Income Statement > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
Revenue

    Back to Income Statement
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

SHUKRA PHARMACEUTICALS Last 5 Year Revenue History

[Standalone]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹57 Cr₹33 Cr₹75 Cr₹59 Cr₹20 Cr

What is the latest Revenue of SHUKRA PHARMACEUTICALS ?

The latest Revenue ratio of SHUKRA PHARMACEUTICALS is ₹57 Cr based on Mar2026 Standalone results.
Year Revenue
Mar2026₹57 Cr
Mar2025₹33 Cr
Mar2024₹75 Cr
Mar2023₹59 Cr
Mar2022₹20 Cr

How is Revenue of SHUKRA PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹57 Cr
74.01
Mar2025 ₹33 Cr
-56.30
Mar2024 ₹75 Cr
26.75
Mar2023 ₹59 Cr
187.19
Mar2022 ₹20 Cr -

Compare Revenue of peers of SHUKRA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS ₹3,194.9 Cr 20% 39.4% 99.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,120.0 Cr -3.2% -5.4% 12% Stock Analytics
DIVIS LABORATORIES ₹253,390.0 Cr 0.7% 3.2% 61.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,740.0 Cr -2.8% -3% 32.6% Stock Analytics
CIPLA ₹108,497.0 Cr -2.9% -3.3% -10.4% Stock Analytics
DR REDDYS LABORATORIES ₹100,925.0 Cr -3.3% 4.7% -2.2% Stock Analytics


SHUKRA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SHUKRA PHARMACEUTICALS

20%

39.4%

99.5%

SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses